Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Retatrutide for Sale > 99% purity Peptide Weight Loss Peptide Retatrutide Adipotide Mazdutide Tirz Sema Cagrilintide Mt2 Peptide 10mg
99% purity Peptide Weight Loss Peptide Retatrutide Adipotide Mazdutide Tirz Sema Cagrilintide Mt2 Peptide 10mg buy - large image1
99% purity Peptide Weight Loss Peptide Retatrutide Adipotide Mazdutide Tirz Sema Cagrilintide Mt2 Peptide 10mg buy - image1
99% purity Peptide Weight Loss Peptide Retatrutide Adipotide Mazdutide Tirz Sema Cagrilintide Mt2 Peptide 10mg buy - image2
99% purity Peptide Weight Loss Peptide Retatrutide Adipotide Mazdutide Tirz Sema Cagrilintide Mt2 Peptide 10mg buy - image3
99% purity Peptide Weight Loss Peptide Retatrutide Adipotide Mazdutide Tirz Sema Cagrilintide Mt2 Peptide 10mg buy - image4
99% purity Peptide Weight Loss Peptide Retatrutide Adipotide Mazdutide Tirz Sema Cagrilintide Mt2 Peptide 10mg buy - image5
99% purity Peptide Weight Loss Peptide Retatrutide Adipotide Mazdutide Tirz Sema Cagrilintide Mt2 Peptide 10mg buy - image6

99% purity Peptide Weight Loss Peptide Retatrutide Adipotide Mazdutide Tirz Sema Cagrilintide Mt2 Peptide 10mg

TDS 7471 Inquiries

Unit Price:

$6-7/MT FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Research Grade

Content:

99%

Port:

Guangzhou

Brand:

1

Packaging:

10mg 15mg 20mg 30mg 50mg 60mg Vial

Sample Available:

Yes

Price valid (until):

2030-12-28

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents
Average Lead Time:
1 days
Qualification:
Main Products:

11

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Our company specializes in exporting various chemical products, including chemical raw materials, a full range of peptide products, and cosmetic raw materials.

    We will provide you with high quality products at the best offer. Professional transportation, convenient and safe, door-to-door delivery.

      Customers who have ordered our products(peptides)have had very good feedback.

    World wide relaible buyers can contact us about the peptides.


    What is Retatrutide?


    Retatrutide is a triple glucagon, GIP, and receptor agonist. Retatrutide showed glucose control and weight loss in patients with type 2 diabetes mellitus (T2DM).Retatrutide (LY3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor . Retatrutide can be used for the research of obesity.Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual:Handling and Storage of Synthetic Peptides. Retatrutide is a new weight loss drug being experimented on by Eli Lilly, a pharmaceutical giant renowned for its breakthrough in diabetes and obesity treatment. Much like other weight loss drugs rolled out by Eli Lilly, Retatrutide is administered under the skin (subcutaneous route) per week and has yielded exceptional results in treating chronic diseases like diabetes and obesity compared to the predecessors.

    Function

    1. 1.Treatment of depression and anxiety disorders:  Retatrutide has been shown to have antidepressant and anxiolytic effects in preclinical studies, suggesting that it could be a promising treatment option for individuals with these conditions.
    2. 2.Prevention of neurodegenerative diseases:  Retatrutide  has neuroprotective properties that may be useful in preventing or slowing the progression of neurodegenerative diseases such as Alzheimer's and Parkinson's.
    3. 3.Enhancement of cognitive function:  Retatrutide has been shown to improve learning and memory in animal studies, suggesting that it could have potential as a cognitive enhancer in humans.
    4. 4.Treatment of chronic pain: Retatrutide has been shown to have analgesic effects in preclinical studies, suggesting that it could be a useful treatment option for individuals with chronic pain conditions.
    5. 5.Promotion of wound healing:  Retatrutide  has been shown to accelerate wound healing in animal studies, suggesting that it could have potential as a therapeutic agent for promoting wound healing in humans.

    Application

    1. Retatrutide is often used in the pharmaceutical industry, weight losing, etc.
    2. Retatrutide is a kind of peptide product.
    3. Retatrutide acetate can inhibited GCGR, GIPR and GLP-1R.
    4. Retatrutide acetate is activated by glucagon receptors resulting in significant weight loss and increased energy expenditure.
    5. Retatrutide acetate can be used in studies of obesity.


    Shop Retatrutide 20mg 30mg CAS 2381089-83-2 safe delivery strong Lyophilized powder Vial-Detailed Image 1

    Shop Retatrutide 20mg 30mg CAS 2381089-83-2 safe delivery strong Lyophilized powder Vial-Detailed Image 2

    Shop Retatrutide 20mg 30mg CAS 2381089-83-2 safe delivery strong Lyophilized powder Vial-Detailed Image 3 Shop Retatrutide 20mg 30mg CAS 2381089-83-2 safe delivery strong Lyophilized powder Vial-Detailed Image 4

    Product Name: Retatrutide
    Purity: ≥99%
    Colour White: Powder
    CAS NO. :2381089-83-2
    Molecular Formula: C187H291N45O59

    Custom content:2mg 5mg 10mg 15mg 20mg 30mg 40mg 50mg etc.

    Customized top color:Red Yellow Blue Black Purple White Green

    Storage: Store in cool and dry places, keep away from strong light.

    Packing:

    10mg/vial 10vials/box

    15mg/vial 10vials/box

    20mg/vial 10vials/box

    30mg/vial 10vials/box

    40mg/vial 10vials/box

    50mg/vial 10vials/box

    Shop Retatrutide 20mg 30mg CAS 2381089-83-2 safe delivery strong Lyophilized powder Vial-Detailed Image 5


    Real customer case:

    Shop Retatrutide 20mg 30mg CAS 2381089-83-2 safe delivery strong Lyophilized powder Vial-Detailed Image 5

    Shop Retatrutide 20mg 30mg CAS 2381089-83-2 safe delivery strong Lyophilized powder Vial-Detailed Image 6 Shop Retatrutide 20mg 30mg CAS 2381089-83-2 safe delivery strong Lyophilized powder Vial-Detailed Image 7

    Shop Retatrutide 20mg 30mg CAS 2381089-83-2 safe delivery strong Lyophilized powder Vial-Detailed Image 8

    Shop Retatrutide 20mg 30mg CAS 2381089-83-2 safe delivery strong Lyophilized powder Vial-Detailed Image 9

    Shop Retatrutide 20mg 30mg CAS 2381089-83-2 safe delivery strong Lyophilized powder Vial-Detailed Image 10

    Shop Retatrutide 20mg 30mg CAS 2381089-83-2 safe delivery strong Lyophilized powder Vial-Detailed Image 11

    OEM service:

    1. Customized logo
    2. Customized label, packing box as customer's requirement
    3. Cap color can be customized

    Any interest please send us inquiries and tell us how to reach you out, we will reply within 24 hours.


    Shipping service:

    Items Specifications
    Before ordering Please send what items and what quantity you need
    Send quotation We will send you a quotation in detail with total
    Payment ways chosen Please choose one of the payment way you preferred.
    Our payment ways: Bank wire, Wise
    After payment Please offer shipping address after payment for shipment.
    Tracking We will provide the tracking after goods sent
    Lead time About 1-5 working days after payment
    Shipping time About 8-15 days door to door
    After-sale service Available always

    Packing and Transport


    We have professional packaging and shipping services

    Shop Retatrutide 20mg 30mg CAS 2381089-83-2 safe delivery strong Lyophilized powder Vial-Detailed Image 4



    Shop Retatrutide 20mg 30mg CAS 2381089-83-2 safe delivery strong Lyophilized powder Vial-Detailed Image 14

    Why choose us:
    1. All peptides and raws purity >=99% purity
    2. 100% Safe delivery
    3.Reasonable & competitive price, fast lead time.
    4.Faster delivery:Sample order in stock and one week for bulk production.
    5. Any inquiries will be replied within 24 hours.


      company pictures


    Shop Retatrutide 20mg 30mg CAS 2381089-83-2 safe delivery strong Lyophilized powder Vial-Detailed Image 14 Shop Retatrutide 20mg 30mg CAS 2381089-83-2 safe delivery strong Lyophilized powder Vial-Detailed Image 15 Shop Retatrutide 20mg 30mg CAS 2381089-83-2 safe delivery strong Lyophilized powder Vial-Detailed Image 16


    FAQ

    Q1: About the after-sale service
    A: After purchasing the products from our Lab, we have A professional technical team and after-sales team to serve you and solve all your problems in the future

    Q2: Can I get some samples?
    A: Yes, we can provide samples, but the customer will pay the freight.

    Q3: How do I start paying?
    Payment can be made by Bitcoin,wire transfer or paypal

    Q4: How to confirm product quality before placing an order?
    A: We got good feedback from customers and Tested by third-party institutions. You also can get free samples of some products. You just have to pay the shipping fee for the sample .
    You can send us your product specifications and requirements and we can customize for you.

    Q5: What is your MOQ?
    A: The minimum quantity we can order is 1 box.
    But usually we can accept a smaller quantity, say 100g, at the cost of 100% sample charge.

    Q6: Time for delivery?
    A: Leading time within 3 business days,Shipping time about 8-10 business days. 

    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Certificates

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Categories:

    Polypeptide

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    11

    Location:

    huayin

    Payment Terms:

    TT against copy of documents

    Average lead Time:

    1 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    5-10

    Year of Establishment:

    2023

  • Inquiry History
    7471 Inquiries
    Country Product Purchase Quantity Date Posted
    Spain

    retatrutide

    200 MG Oct 27, 2026
    United States

    Retatrutide

    100 PCS Oct 27, 2026
    New Zealand

    Retatrutide

    20 PCS Oct 27, 2026
    Netherlands

    Retatrutide

    100 20' Fcl Oct 27, 2026
    United States

    Retatrutide

    300 MG Oct 27, 2026
    Canada

    Retatrutide

    1 G Oct 26, 2026
    Switzerland

    Retatrutide

    1 KG Oct 26, 2026
    United States

    Retatrutide

    10 MG Oct 26, 2026
    Australia

    Retatrutide

    30 MG Oct 26, 2026
    United States

    Retatrutide

    30 MG Oct 26, 2026
    United States

    Tesa

    2 MG Oct 25, 2026
    Colombia

    Retatrutide

    15 MG Oct 25, 2026
    United States

    Retatrutide

    10 G Oct 25, 2026
    Canada

    Retatrutide

    1 KG Oct 25, 2026
    United Kingdom

    Retatrutide

    1 G Oct 25, 2026
    Netherlands

    Retatrutide

    10 MG Oct 25, 2026
    Australia

    Retatrutide

    10 MG Oct 25, 2026
    Netherlands

    Retatrutide

    20 MG Oct 25, 2026
    Germany

    Retatrutide

    1 KG Oct 25, 2026
    United Kingdom

    Retatrutide

    10 G Oct 25, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.